13.56
전일 마감가:
$13.75
열려 있는:
$13.58
하루 거래량:
2.46M
Relative Volume:
1.11
시가총액:
$3.86B
수익:
$1.16B
순이익/손실:
$77.95M
주가수익비율:
50.02
EPS:
0.2711
순현금흐름:
$144.80M
1주 성능:
+1.80%
1개월 성능:
-22.07%
6개월 성능:
-13.24%
1년 성능:
+10.78%
소테라헬스 Stock (SHC) Company Profile
명칭
Sotera Health Co
전화
440-262-1410
주소
9100 SOUTH HILLS BLVD, SUITE 300, BROADVIEW HEIGHTS
Compare SHC vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
SHC
Sotera Health Co
|
13.56 | 3.91B | 1.16B | 77.95M | 144.80M | 0.2711 |
|
TMO
Thermo Fisher Scientific Inc
|
470.21 | 172.63B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
190.11 | 135.42B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
579.85 | 45.95B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.75 | 31.51B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
299.57 | 28.94B | 3.17B | 642.63M | 516.49M | 10.77 |
소테라헬스 Stock (SHC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-09 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2026-01-09 | 재개 | RBC Capital Mkts | Outperform |
| 2025-12-18 | 개시 | William Blair | Outperform |
| 2025-11-13 | 개시 | BMO Capital Markets | Outperform |
| 2025-05-05 | 업그레이드 | Goldman | Neutral → Buy |
| 2024-12-06 | 개시 | Goldman | Neutral |
| 2024-05-21 | 개시 | Piper Sandler | Neutral |
| 2024-04-03 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-03-25 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-02-06 | 재개 | KeyBanc Capital Markets | Sector Weight |
| 2023-06-26 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-23 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2023-01-11 | 업그레이드 | Barclays | Underweight → Overweight |
| 2023-01-11 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2022-11-15 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2022-10-05 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-09-26 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-09-21 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2022-09-20 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-06-09 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-03-03 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-03-02 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2021-01-14 | 개시 | Robert W. Baird | Outperform |
| 2020-12-15 | 개시 | Citigroup | Buy |
| 2020-12-15 | 개시 | Credit Suisse | Outperform |
| 2020-12-15 | 개시 | Goldman | Buy |
| 2020-12-15 | 개시 | JP Morgan | Overweight |
| 2020-12-15 | 개시 | Jefferies | Buy |
| 2020-12-15 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | 개시 | RBC Capital Mkts | Outperform |
모두보기
소테라헬스 주식(SHC)의 최신 뉴스
Sotera Health Co Stock (ISIN: US8293551086) Holds Steady Amid Sterilization Sector Resilience and He - AD HOC NEWS
Aug Levels: What is the target price for Sotera Health Company stock2026 Market Sentiment & Stock Timing and Entry Methods - baoquankhu1.vn
Sotera Health adds pest-control CFO to board after another director exits - Crain's Cleveland
Sotera Health Company (NASDAQ:SHC) Sees Significant Growth in Short Interest - MarketBeat
Sotera Health appoints Kenneth D. Krause to board following director resignation - Investing.com Nigeria
Sotera Health appoints Kenneth Krause to board of directors - Investing.com
Kenneth Krause joins Sotera Health (NASDAQ: SHC) board, audit committee - Stock Titan
Pest-control CFO joins Sotera Health board as director Mihas exits - Stock Titan
Sotera Health Shares Rise 18% in a Year. Here's What a $37 Million Stake Trim Signals - The Motley Fool
Sotera Health at Barclays Conference: Strategic Growth and Legal Challenges - Investing.com
Sotera Health Board Member Trades $229.05M In Company Stock - Benzinga
Insider Transaction: WARBURG PINCUS CO Sells $229.05M Worth Of Sotera Health Shares - Benzinga
Warburg Pincus trims Sotera Health (SHC) stake with 15M-share secondary sale - Stock Titan
Warburg Pincus entities cut Sotera Health (SHC) stake with 15M-share sale - Stock Titan
Warburg Pincus amendment: holds 11.2% of Sotera Health (NYSE: SHC) - Stock Titan
GTCR lists 11.2% stake in Sotera Health (NYSE: SHC) via joint disclosure - Stock Titan
SHC Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Sotera Health Company (NASDAQ:SHC) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Sotera Health stockholders sell 25 million shares in secondary offering - Investing.com India
Sotera Health stockholders sell 25 million shares in secondary offering By Investing.com - Investing.com Canada
Sotera Health Ownership Shift As 25m Share Sale Tests Valuation - simplywall.st
Sotera Health (NASDAQ:SHC) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Wells Fargo Manages Offering for SHC - GuruFocus
Sotera Health shares fall 4.2% as private equity firms launch secondary offering By Investing.com - Investing.com South Africa
Sotera Health shares fall 4.2% as private equity firms launch secondary offering - Investing.com
Sotera Health Up 30% This Past Year, so Why Did One Fund Sell $4 Million in Shares? - AOL.com
Sotera Health (SHC) CFO gets new RSUs as shares withheld for tax - Stock Titan
Sotera Health (SHC) Launches 25 Million Share Secondary Offering - GuruFocus
Form 424B7 Sotera Health Co - StreetInsider
Warburg Pincus and GTCR affiliates to sell 25M Sotera Health shares - Stock Titan
SHC SEC FilingsSotera Health Co 10-K, 10-Q, 8-K Forms - Stock Titan
SHC Stock Price and Chart — NASDAQ:SHC - TradingView
Sotera Health Company (SHC) Stock Analysis: Exploring a 30% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Sotera Health (SHC) Loses 13% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Finviz
Assessing Sotera Health (SHC) Valuation After Strong 2025 Results And 2026 Growth Guidance - simplywall.st
Sotera Health (SHC) Is Down 7.1% After Issuing 2026 Revenue Guidance And Marking 20th Growth Year - simplywall.st
SHC Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
SHC Should I Buy - Intellectia AI
Panel: Investors Failed To Show Sterilization Facility Owner Committed Fraud - Law360
FRAUD AND MANIPULATION—6th Cir.: Sterigenics class action dismissal affirmed by the Sixth Circuit - VitalLaw.com
Sotera Health wins appeal of investor lawsuit - Crain's Cleveland
Sotera Health is Now Oversold (SHC) - Nasdaq
Sotera Prevails in Investor Appeal of Emissions Disclosures Suit - Bloomberg Law News
Sotera Health: Strengthening Fundamentals, Margin Expansion, and Deleveraging Support Buy Rating and $20 Target - TipRanks
Sotera Health Company (NASDAQ:SHC) Q4 2025 Earnings Call Transcript - Insider Monkey
Sotera Health Company (SHC) Stock Analysis: A 16.85% Potential Upside In Healthcare Diagnostics - DirectorsTalk Interviews
Sotera Health Q4 2025 slides: 20th year of growth, margins hit 51% - Investing.com Australia
Decoding Sotera Health Co (SHC): A Strategic SWOT Insight - GuruFocus
6th Circ. Affirms Dismissal Of Sotera Toxic Gas Investor Suit - Law360
SHC: Citigroup Maintains "Buy" Rating, Raises Price Target to $2 - GuruFocus
Sotera Health (SHC) Margin Expansion To 6.7% Tests Premium 60.9x P/E Narrative - simplywall.st
소테라헬스 (SHC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):